Oxidative damage in an esophageal adenocarcinoma model with rats

Carcinogenesis

Volumn 21, Issue 2, 2000, Pages 257-263

  Chen, Xiaoxin ^a   Ding, Yu Wei ^a   Yang, Guang Yu ^a   Bondoc, Flordeliza ^a   Lee, Mao Jun ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; DNA; IRON; LIPID; PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CONTROLLED STUDY; DNA DAMAGE; ESOPHAGITIS; ESOPHAGUS CARCINOMA; IRON BLOOD LEVEL; IRON OVERLOAD; IRON THERAPY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0033956282     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.2.257     Document Type: Article

References (44)

1. Blot, W.J., Devesa, S.S., Kneller, R.W. and Fraumeni, J.F. (1991) Rising incidence of adenocarcinoma of the esopahgus and gastric cardia. J. Am. Med. Assoc., 265, 1287-1289.
2. Blot, W.J., Devesa, S.S. and Fraumeni, J.F. (1993) Continuing climb in rates of esophageal adenocarcinoma: an update. J. Am. Med. Assoc., 270, 1320.
3. Pera, M., Cameron, A.J., Trastek, V.F., Carpenter, H.A. and Zinsmeister, A.R. (1993) Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology, 104, 510-513.
4. Farrow, D.C. and Vaughan, T.L. (1996) Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control, 7, 332-327.
5. Altorki, N.K., Oliveria, S. and Schrump, D.S. (1997) Epidemiology and molecular biology of Barrett's adenocarcinoma. Semin. Surg. Oncol., 13, 270-280.
6. Corder, A.P., Jones, R.H., Sadler, G.H., Daniels, P. and Johnson, C.D. (1996) Heartburn, esophagitis and Barrett's esophagus in self-medicating patients in general practice. Br. J. Clin. Pract., 50, 245-248.
7. Isolauri, J., Luostarinen, M., Isolauri, E., Reinikainen, P. and Viljakka, M. (1997) Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am. J. Gastroenterol., 92, 37-41.
8. Cameron, A.J., Ott, B.J. and Payne, W.S. (1990) Prevalence of columnarlined (Barrett's) esophagus. Gasteroenterology, 103, 1241-1245.
9. Cameron, A.J. (1997) Barrett's esophagus: Does the incidence of adenocarcinoma matter? Am. J. Gastroenterol., 92, 193-194.
10. Olyaee, M., Sontag, S., Salman, T., Schnell, T., Mobarhan, S., Eiznhamer, D. and Keshavarzian, A. (1995) Mucosal reactive oxygen species production in esophagitis and Barrett's esophagus. Gut, 37, 168-173.
11. Wetscher, G.J., Hinder, R.A., Gadenstatter, M., Perdikis, G. and Hinder, P.R. (1997) Reflux esophagitis in humans is a free radical event. Dis. Esoph., 10, 29-32.
12. Fleisher, A.S., Dutta, S.K., Collawn, C., Vengurlekar, S.M., Iyergar, V. and Siverstein, R.J. (1995) Effects of beta-carotene therapy on symptomatic, endoscopic and histologic parameters in patients with Barrett's esophagus. Am. J. Gastroenterol., 90, A1558.
13. Tavari, A., Negri, E., Franceschi, S. and Vecchia, C. (1994) Risk factors for esophageal cancer in lifelong nonsmokers. Cancer Epidemiol. Biomarkers Prev., 3, 387-392.
14. Zhang, Z.-F., Kurtz, R.C. and Marshall, J.R. (1997) Cigarette smoking and esophageal and gastric cardia adenocarcinoma. J. Natl Cancer Inst., 89, 1247-1249.
15. Attwood, S.E., Smyrk, T.C., DeMeester, T.R., Mirvish, S.S., Stein, H.J. and Hinder, R.A. (1992) Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery, 111, 503-510.
16. Goldstein, S.R., Yang, G.-Y., Curtis, S.K., Reuhl, K.R., Liu, B.-C., Mirvish, S.S., Newmark, H.L. and Yang, C.S. (1997) Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis, 18, 2265-2270.
17. Mirvish, S.S. (1997) Studies on experimental animals involving surgical procedures and/or nitrosamine treatment related to the etiology of esophageal adenocarcinoma. Cancer Lett., 117, 161-174.
18. Goldstein, S.R., Yang, G.-Y., Chen, X., Curtis, S.K. and Yang, C.S. (1998) Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma. Carcinogenesis, 19, 1445-1449.
19. Hetzel, D.J., Dent, J., Reed, W.D., Narielwala, F.M., Mackinnon, M. and McCarthy, J.H. (1988) Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology, 95, 903-912.
20. Lewin, K.J. and Appelman, H.D. (1995) Barrett's esophagus, columnar dysplasia and adenocarcinoma of the esophagus. In Lewin, K.J. and Appelman, H.D. (eds) Tumors of the Esophagus and Stomach. AFIP, Washington, DC, pp. 99-144.
21. Nguyen-Legros, J., Bizot, J., Bolesse, M. and Pulicani, J.P. (1980) Diaminobenzidine black as a new histochemical demonstration of exogenous iron. Histochemistry, 66, 239-244.
22. Wong, S.H.Y., Knight, J.A., Hopfer, S.M., Zaharia, O., Leach, C.N. and Sunderman, F.W. (1987) Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin. Chem., 33, 214-220.
23. Reznick, A.Z. and Packer, L. (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Method Enzymol., 233, 357-363.
24. Jeffrey, G.P., Basclain, K.A. and Allen, T.L. (1996) Molecular regulation of transferrin receptor and ferritin expression in the rat gastrointestinal tract. Gastroenterology, 110, 790-800.
25. Camhi, S.L., Lee, P. and Choi, A.M.K. (1995) The oxidative stress response. New Horizons, 3, 170-182.
26. Lawrence, W. (1977) Nutritional consequences of surgical resection of the gastrointestinal tract for cancer. Cancer Res., 37, 2379-2386.
27. Birgegard, G. and Caro, J. (1984) Increased ferritin synthesis and iron uptake in inflammatory mouse macrophages. Scand. J. Hematol., 33, 43-49.
28. Morris, C.J., Earl, J.R., Trenam, C.W. and Blake, D.R. (1995) Reactive oxygen species and iron - a dangerous partnership in inflammation. Int. J. Biochem. Cell Biol., 27, 109-122.
29. Aust, S.D. (1995) Ferritin as a source of iron and protection from iron-induced toxicities. Toxicol. Lett., 82/83, 941-944.
30. Clark, G.W.B., Smyrk, T.C., Mirvish, S.S., Anselmino, M., Yamashita, Y., Hinder, R.A., DeMeester, T.R. and Birt, D.F. (1994) Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Ann. Surg. Oncol., 1, 252-261.
31. Cardesa, A., Bombi, J.A., Pera, M., Fernandez, P.L., Campo, E., Pera, C. and Mohr, U. (1994) Spectrum of glandular differentiation in experimental carcinoma of the esophagus induced by 2,6-dimethylnitrosomorpholine under the influence of esophagojejunostomy. Exp. Toxicol. Pathol., 46, 41-49.
32. Herbst, J.J., Berenson, M.M., McLoskey, D. and Wiser, W.C. (1978) Cell proliferation in esophageal columnar epithelium. Gastroenterology, 75, 683-687.
33. Sale, G.E., Jakic-Razumovic, J. and Hamilton, B.S. (1991) Evidence supporting the prediction that the squamocolumnar junction of murine forestomach is a site of epithelial stem cells. Bone Marrow Transplant., 8, 237-238.
34. Yoshiji, H., Nakae, D., Mizumoto, Y., Horiguchi, K., Tamura, K., Denda, A., Tsujii, T. and Konishi, Y. (1992) Inhibitory effect of dietary iron deficiency on inductions of putative preneoplastic lesions as well as 8-hydroxydeoxyguanosine in DNA and lipid peroxidation in the livers of rats caused by exposure to a choline-deficient I.-amino acid defined diet. Carcinogenesis, 13, 1227-1233.
35. Toyokuni, S., Okamoto, K., Yodoi, J. and Hiai, H. (1995) Persistent oxidative stress in cancer. FEBS Lett., 358, 1-3.
36. Stocker, R. (1990) Induction of heme oxygenase as a defence against oxidative stress. Free Radic. Res. Cumms., 9, 101-112.
37. Poss, K.D. and Tonegawa, S. (1997) Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl Acad. Sci. USA, 94, 10925-10930.
38. Sato, M. and Bremner, I. (1993) Oxygen free radicals and metallothionein. Free Radic. Biol. Med., 14, 325-337.
39. Schwarz, M.A., Lazo, J.S., Yalowich, J.C., Allen, W.P., Whitmore, M., Bergonia, H.A., Tzeng, E., Billiar, T.R., Robbins, P.D., Lancaster, J.R., Jr and Pitt, B.R. (1995) Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc. Natl Acad. Sci. USA, 92, 4452-4456.
40. Abdel-Mageed, A.B. and Agrawal, K.C. (1997) Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther., 4, 199-207.
41. Zhang, B., Satoh, M., Nishmura, N., Suzuki, J.S., Sone, H., Aoki, Y. and Tohyama, C. (1998) Metallothionein deficiency promotes mouse skin carcinogenesis induced by 7.12-dimethylbenz[a]anthracene. Cancer Res., 58, 4044-4046.
42. Shimada, A., Yanagida, M. and Umemura, T. (1997) An immunohistochemical study on the tissue-specific localisation of metallothionein in dogs. J. Comp. Pathol., 116, 1-11.
43. Jasani, B. and Schmid, K.W. (1997) Significance of metallothionein overexpression in human tumors. Histopathology, 31, 211-214.
44. Maines, M.D. and Abrahamsson, P.-A. (1996) Expression of heme oxygenase-1 in human prostate: normal, hyperplastic and tumor tissue distribution. Urology, 47, 727-733.